about
Predictive models, based on classification algorithms, for compounds potentially active as mitochondrial ATP-sensitive potassium channel openers.Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in VivoNatural modulators of large-conductance calcium-activated potassium channels.Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics.(+/-)-Naringenin as large conductance Ca(2+)-activated K+ (BKCa) channel opener in vascular smooth muscle cells1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII.D-Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase.New emerging prospects in the pharmacotherapy of hypertension.Pharmacodynamic hybrids coupling established cardiovascular mechanisms of action with additional nitric oxide releasing properties.Hydrogen sulphide: novel opportunity for drug discovery.An update on hybrid drugs in cardiovascular drug research.Mitochondrial potassium channels as pharmacological target for cardioprotective drugs.Inhibitors of the renal outer medullary potassium channel: a patent review.Using hydrogen sulfide to design and develop drugs.Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.Hydrogen sulfide inhalation ameliorates allergen induced airway hypereactivity by modulating mast cell activation.Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors.Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels.Novel analgesic/anti-inflammatory agents: diarylpyrrole acetic esters endowed with nitric oxide releasing properties.Synthesis and biological evaluation of 5-membered spiro heterocycle-benzopyran derivatives against myocardial ischemia.Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties.Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel.Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands.Prediction of hERG potassium channel affinity by the CODESSA approach.The novel H2 S donor 4-carboxy-phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium.Anti-ischaemic activity of an antioxidant aldose reductase inhibitor on diabetic and non-diabetic rat hearts.Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors.Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X.New 5-substituted-1-(2-hydroxybenzoyl)-benzotriazoles, potassium channel activators. IV.Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. III.Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts.Conformationally restrained analogues of sympathomimetic catecholamines. Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2',5'-morpholines].Vasodilator activity of crude methanolic extract of Gentiana kokiana Perr. et Song. (Gentianaceae).Hormonal influence on the release of endothelial nitric oxide: gender-related dimorphic sensitivity of rat aorta for noradrenaline.Cardiovascular effects of Urtica dioica L. (Urticaceae) roots extracts: in vitro and in vivo pharmacological studies.R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors.Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.The xanthones gentiacaulein and gentiakochianin are responsible for the vasodilator action of the roots of Gentiana kochiana.Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: identification of beta 3-antagonists.
P50
Q33481422-04B38BB3-E421-410D-BC72-127DDB966C18Q34402692-AEB8DBDE-9F88-4B2A-93C0-D63010F6E6EFQ35181925-0F7C8EC4-3300-4932-9C24-0D2339BE4463Q35597334-9CE61635-753C-4460-AE9B-DF207F858DCEQ36048792-DEF0ACBB-BE22-486C-A0E0-CA0A477EF4D0Q36054330-3DF06D88-2CD0-404F-898B-D7E814F55437Q36135682-1028F5E6-0D6F-4531-82CC-55C53F903B5CQ36797373-433A25B5-361A-4725-AF86-E473FD0E06F1Q37065979-87F859C6-EB4E-4E26-8995-48E3967E42D0Q37387568-08EBA146-620E-4205-9DC0-6E08214C3836Q38051531-AE5B9B20-7B69-4A9A-9031-C93BB5B7FC81Q38090661-C40C143D-B7C0-405A-81B5-E8B289C1EA40Q38262884-FD42532A-703C-4BCF-93D8-4574B768BE51Q38500527-7A1558B7-4E78-44E0-9E1B-BEC4A0CEE386Q38643114-00A722A9-3CAE-40EA-B613-306FBA2A7A9FQ38825213-D3A73A29-5402-44F2-A34E-3DFB09F6F754Q38846453-F932AB16-92CE-464A-864A-8C53E010C728Q39039040-CA4485C3-2546-4D2F-A1D7-B3D2E9A511E8Q39216830-8828F2EB-ADD5-45AE-8B0E-43855AA306E9Q39459414-1FC513A9-C596-4165-A1E5-B94769E78113Q39599014-B3AF4817-7943-4923-920C-347C0CDE3882Q39664910-15AD566C-3526-4C21-ACB5-93D67E1B3680Q39816030-8DD266F8-3DF3-42AC-A959-B8020FCF5FA0Q40163832-F7AFA716-067F-4137-A88F-CB3B0C0BE0A0Q40326863-682D5992-9124-4903-89AA-F416F191B595Q42671662-4A04AD5F-9DE2-4ACB-8949-39FE6EB362F3Q42932522-1EB2505C-3F7B-4F05-A5A8-8796B0842EBFQ43583233-96E27877-3BEB-469F-A106-C725B0E5F9EAQ43832562-60887C33-8346-4657-94B8-E89A0C4350E1Q43838651-E87D2237-B4F1-4610-995D-3F0A60D0BC2FQ43838657-211B3E8F-DCB8-4424-8726-01DCDBF01F49Q43849364-66F1183B-0DA9-4977-B200-366889AA2A16Q43884074-961680F0-1F7A-42FE-9327-FCB02AFD149DQ43890095-F97CCDE6-A079-4FA0-BA40-B4AE63D4551BQ43985272-D60FAA1C-C663-4518-B147-BAE75ABF19F6Q44000396-BC94C70B-24B5-4C73-BA5F-1AD51ADBEDFEQ44264992-CBEB4578-52EF-41E1-943F-C3A01D311D78Q44540235-5F791C5B-5B62-4727-838D-A05C0A484221Q44609308-19BBA752-3842-4181-A9DD-4D7A97891FACQ44646663-D0053734-B224-44BF-8DAD-1ABB1C9950A6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Vincenzo Calderone
@ast
Vincenzo Calderone
@en
Vincenzo Calderone
@es
Vincenzo Calderone
@nl
type
label
Vincenzo Calderone
@ast
Vincenzo Calderone
@en
Vincenzo Calderone
@es
Vincenzo Calderone
@nl
altLabel
VINCENZO CALDERONE
@en
prefLabel
Vincenzo Calderone
@ast
Vincenzo Calderone
@en
Vincenzo Calderone
@es
Vincenzo Calderone
@nl
P1053
L-9288-2015
P106
P1153
7004676427
P2038
Vincenzo_Barrese
P21
P2798
P31
P3829
P496
0000-0002-1441-5421